Sachchithanantham, S;    Berlanga, O;    Alvi, A;    Mahmood, SA;    Lachmann, HJ;    Gillmore, JD;    Hawkins, PN;         ... Wechalekar, AD; + view all <#>        Sachchithanantham, S;  Berlanga, O;  Alvi, A;  Mahmood, SA;  Lachmann, HJ;  Gillmore, JD;  Hawkins, PN;  Harding, S;  Wechalekar, AD;   - view fewer <#>    (2017)    Immunoparesis defined by heavy plus light chain suppression is a novel marker of long-term outcomes in cardiac AL amyloidosis.                   British Journal of Haematology , 179  (4)   pp. 575-585.    10.1111/bjh.14908 <https://doi.org/10.1111/bjh.14908>.       Green open access